Citius Oncology, Inc. CTOR Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$24.76M-17.1% | -$21.15M-66.6% | ||
| $8.32M+11.0% | $7.5M+282% | ||
| -$5.49M-1,088% | $555.64K— | ||
| -$5.75M+24.0% | -$7.57M+88.8% | ||
| —— | $2.36M— | ||
| —— | —— | ||
| $15.17M+115% | $7.05M— | ||
| $3.92M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Citius Oncology, Inc. generate?
- Citius Oncology, Inc. (CTOR) generated -$13.9M in operating cash flow over the trailing twelve months.
- Where does Citius Oncology, Inc.'s cash flow data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.